新しい評価法を用いたシャープカット型感音難聴の検討 : 異聴地図とDLSI不定幅にみる特徴
スポンサーリンク
概要
- 論文の詳細を見る
Abrupt high tone loss in perceptive hearing-impaired patients were investigated by means of Bekesys self-recording audiometry, DLSI test and a Japanese monosyllable speech audiometry. Two new methods were applied for evaluations of DLSI test and the speech audiometry. Statisti-cal observations were made in regard to the cut-off frequencies, the reduction on the amplitude of the continuous tracing and the gradient of steep incline portion by Bekesys self-recording audiometry. No case showed any abnormal DLSI values which suggested the retrocochlear lesions. Also there was no case showing abnormal low speech cognitive ability indices which were proposed in our previous paper. Therefore, there would be little possibilities of retrocochlear lesions in subjects showing this type of hearing impairment.Two new methods were also applied to these patients. Comparative study of DLSI value and newly proposed the width of uncertainty in DLSI was carried out in lower and higher frequencies than cut-off frequency. The width of uncertainty in DLSI may represent a part of feature in this type of hearing disorder from the results of this comparative study. Each patients confusion chart was made by using the speech chart on which each patients confusion was superimposed and drawn. The tendency of confusion was examined by making the confusion charts according to each cut-off frequency group respectively, and characteristics of confusion were clearly identified. As a conclu-sion, all the results in this study indicated that the main lesion of this type of hearing-impaired patients located at in the inner ear.
論文 | ランダム
- Anticonvulsant Activity and Effects of Sodium Dipropylacetate on Cerebral 5-Hydroxytryptamine and γ-Aminobutyric Acid in Reserpinized Mice
- Effects of Sodium Dipropylacetate on γ-Aminobutyric Acid and Biogenic Amines in Rat Brain
- Establishing the First Oral Health Care Center for People with Disabilities in Taiwan
- 膀胱自然破裂の1例 : 第299回北海道地方会
- EFFECTS OF N-(4-METHYLBENZYLTHIOCARBONYL)-L-PHENYLALANINE (KF 1492), A NEW HYPOLIPIDEMIC DRUG, AND CLOFIBRATE ON LIPIDS METABOLISM